ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $28,202,000 | +21.6% | 5,009,362 | +18.6% | 26.68% | +19.9% |
Q2 2016 | $23,184,000 | -0.9% | 4,223,040 | +33.9% | 22.26% | -6.5% |
Q1 2016 | $23,396,000 | +17.4% | 3,153,040 | +31.5% | 23.80% | -7.8% |
Q4 2015 | $19,927,000 | +24.2% | 2,398,040 | +34.6% | 25.82% | -5.2% |
Q3 2015 | $16,047,000 | -20.5% | 1,781,040 | +5.8% | 27.24% | +21.7% |
Q2 2015 | $20,197,000 | +46.1% | 1,683,064 | +31.2% | 22.39% | +59.3% |
Q1 2015 | $13,821,000 | +52.6% | 1,283,204 | -28.2% | 14.06% | +57.1% |
Q4 2014 | $9,059,000 | +209.5% | 1,786,700 | +61.2% | 8.94% | +289.9% |
Q3 2014 | $2,927,000 | -61.7% | 1,108,700 | -41.5% | 2.29% | -58.4% |
Q2 2014 | $7,642,000 | -26.5% | 1,896,222 | -16.5% | 5.51% | -36.9% |
Q1 2014 | $10,396,000 | -6.6% | 2,269,925 | -11.5% | 8.74% | -2.8% |
Q4 2013 | $11,132,000 | – | 2,564,925 | – | 8.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |